BIOMAT Database Logo BIOMAT Database Logo

HLA-DR specificities among Japanese with rheumatoid arthritis. 1981

T Sakurami, and Y Ueno, and H Okumura, and P I Terasaki, and M S Park, and S Louie, and S Takemura

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D015804 HLA-DR4 Antigen An HLA-DR antigen which is associated with HLA-DRB1 CHAINS encoded by DRB1*04 alleles. HLA-DR4,Antigen, HLA-DR4,HLA DR4 Antigen

Related Publications

T Sakurami, and Y Ueno, and H Okumura, and P I Terasaki, and M S Park, and S Louie, and S Takemura
Positive and negative association of HLA-DR genotypes with Japanese rheumatoid arthritis.
January 1996, Clinical and experimental rheumatology,
T Sakurami, and Y Ueno, and H Okumura, and P I Terasaki, and M S Park, and S Louie, and S Takemura
[HLA-DR in rheumatoid arthritis].
January 1985, Terapevticheskii arkhiv,
T Sakurami, and Y Ueno, and H Okumura, and P I Terasaki, and M S Park, and S Louie, and S Takemura
HLA-DR shared epitope in familial cases of Japanese rheumatoid arthritis.
January 2000, Clinical and experimental rheumatology,
T Sakurami, and Y Ueno, and H Okumura, and P I Terasaki, and M S Park, and S Louie, and S Takemura
Distribution of HLA-DR alleles among Thai patients with rheumatoid arthritis.
March 2015, Human immunology,
T Sakurami, and Y Ueno, and H Okumura, and P I Terasaki, and M S Park, and S Louie, and S Takemura
Association of HLA-DR antigens with disease severity in Japanese patients with rheumatoid arthritis.
August 1990, The Kobe journal of medical sciences,
T Sakurami, and Y Ueno, and H Okumura, and P I Terasaki, and M S Park, and S Louie, and S Takemura
HLA DR antigens in rheumatoid arthritis.
January 1983, Scandinavian journal of rheumatology,
T Sakurami, and Y Ueno, and H Okumura, and P I Terasaki, and M S Park, and S Louie, and S Takemura
[Rheumatoid arthritis: its relationship with HLA DR molecules].
May 1995, Presse medicale (Paris, France : 1983),
T Sakurami, and Y Ueno, and H Okumura, and P I Terasaki, and M S Park, and S Louie, and S Takemura
HLA-DR specificities among black Americans with juvenile-onset diabetes.
October 1979, The New England journal of medicine,
T Sakurami, and Y Ueno, and H Okumura, and P I Terasaki, and M S Park, and S Louie, and S Takemura
Antibody to a specific HLA-DR beta 1 sequence in Japanese patients with rheumatoid arthritis.
December 1990, Arthritis and rheumatism,
T Sakurami, and Y Ueno, and H Okumura, and P I Terasaki, and M S Park, and S Louie, and S Takemura
Protective HLA-DR phenotypes in rheumatoid arthritis.
April 1989, The Journal of rheumatology,
Copied contents to your clipboard!